-
Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Definitive Proof of Concept Data for its Second Oncology Candidate (VTX-0P4) in a Prostate Stem Cell Antigen (PSCA) Related Tumor Study in Combination with a Checkpoint…
29 May 2025 12:18 GMT
… of cancers over-expressing prostate stem cell antigen (PSCA). VTX-0P4 is … mechanism of action.” This important research and development milestone further demonstrates … , Inc. Voltron Therapeutics, Inc., a Delaware corporation, was founded in 2017 …
-
Why Meatpacker JBS's IPO Matters for the Planet
05 Aug 2025 10:01 GMT
… Global Sustainability in Focus: TGM Research Highlights Everyday Actions, Challenges, and … ; Friends™ Returns to The Delaware River Railroad Excursions for an … Director of Studio Operations
R3 Stem Cell Wins Global Regenerative Medicine Company …
-
Stem Cell Umbilical Cord Blood Market to Reach $10.13 Bn, Globally, by 2027 at 16.9% CAGR
12 Mar 2025 12:58 GMT
… report, the global stem cell umbilical cord blood industry … half of the global stem cell umbilical cord blood market … fifths of the global stem cell umbilical cord blood market … based in Wilmington, Delaware. Allied Market Research provides global enterprises …
-
Global Cryopreservation Freezers Market to Reach USD 1,233.7 Million by 2035, Driven by Advancements in Regenerative Medicine and Stem Cell Banking | Future Market Insights, Inc.
05 Mar 2025 08:30 GMT
… advancements in regenerative medicine, increasing stem cell banking, automation in biobanking, and … , with a strong focus on stem cell research, organ preservation, and biomedical advancements … Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1 …
-
Instinct Brothers Co., Ltd, a Japanese Vertically Integrated Regenerative Medicine & Stem Cell Technology Company, to Go Public via Merger with Relativity Acquisition Corp.
04 Mar 2025 13:00 GMT
… an ecosystem that integrates stem-cell-based cosmeceuticals, research and development, university partnerships … Relativity Acquisition Sponsor LLC, a Delaware limited liability company, formed for …
-
Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™
18 Feb 2025 14:25 GMT
… concerns surrounding the use of stem cell therapy or human tissue; our … able to secure and maintain research institutions to conduct our clinical … of incorporation and bylaws and Delaware law might discourage, delay or …
-
Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware
29 Apr 2025 10:57 GMT
… beginning.”
With proximity to Delaware and Pennsylvania universities, Merck … enhance our domestic manufacturing and research capabilities, with additional planned … KEYTRUDA.
Complications of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Fatal and …
-
Cell Counting Market is expected to generate a revenue of USD 16.5 Billion by 2031, Globally, at 6.20% CAGR: Verified Market Research®
22 Apr 2025 15:00 GMT
Lewes, Delaware, April 22, 2025 (GLOBE NEWSWIRE … Cell Counters
Manual Cell Counters
Stem Cell Research
Cell-Based Therapeutics
Bioprocessing
… Type (Consumables, Instruments), Application (Stem Cell Research, Cancer Research, Immunology, Drug Discovery and …
-
Stem Cell Therapy Market is expected to generate a revenue of USD 31.41 Billion by 2030, Globally, at 13.95% CAGR: Verified Market Research®
25 Nov 2024 15:15 GMT
… Delaware, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The Global Stem Cell Therapy … the latest technological advancements in stem cell research, including CRISPR gene editing … market growth. Advancements in Stem Cell Research: Technological advancements, such as …
-
Animal Stem Cell Therapy Market to Reach $440.0 Million, Globally, by 2033 at 5.6% CAGR: Allied Market Research
21 Nov 2024 06:13 GMT
… innovation, fostering extensive research and development in animal stem cell therapies. Collaborative efforts … LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as …
About
© 1995-2025